tiprankstipranks
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market

Aprea Therapeutics (APRE) Income Statement

Compare
457 Followers

Aprea Therapeutics Income Statement

Last quarter (Q3 2024), Aprea Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Aprea Therapeutics's net income was $-3.78M. See Aprea Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 583.23K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 576.18K$ -186.44K$ -271.68K$ -229.61K$ -170.25K
Operating Expenses
$ 16.05M$ 37.37M$ 37.45M$ 52.81M$ 29.54M
Depreciation and Amortization
-$ 186.44K$ 271.68K$ 229.61K$ 170.25K
EBITDA
$ -14.28M$ -112.48M$ -36.86M$ -53.25M$ -27.89M
Operating Income
$ -15.47M$ 38.18M$ -38.04M$ -52.15M$ -31.04M
Other Income/Expenses
$ 1.19M$ -75.29M$ 319.05K$ -667.60K$ 1.48M
Pretax Income
$ -14.29M$ -112.66M$ -37.13M$ -53.48M$ -28.06M
Net Income
$ -14.29M$ -224.88M$ -36.54M$ -53.92M$ -26.41M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.95$ -2.71K$ -34.33$ -51.02$ -26.28
Diluted EPS
$ -3.95$ -2.71K$ -34.33$ -51.02$ -26.28
Weighted Average Shares Outstanding
3.62M 82.85K 1.06M 1.06M 1.00M
Weighted Average Shares Outstanding (Diluted)
3.62M 82.85K 1.06M 1.06M 1.00M
Currency in USD

Aprea Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis